Scarica l'app Stockscreener
99.10
1.39%
1.36
Dopo l'orario di chiusura:
98.00
-1.10
-1.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Incyte Corp Borsa (INCY) Ultime notizie
INCY Maintained by Oppenheimer -- Price Target Raised to $90 - GuruFocus
Incyte to Present at Upcoming May 2026 Investor Conferences - BioSpace
Stifel raises Incyte stock price target to $123 on earnings beat - Investing.com Canada
INCY Maintained by Stifel -- Price Target Raised to $123 - GuruFocus
H.C. Wainwright reiterates Incyte stock rating on Jakafi outlook - Investing.com
Incyte Corporation (NASDAQ:INCY) Q1 2026 Earnings Call Transcript - Insider Monkey
Two May Incyte conference presentations will stream live online - Stock Titan
Incyte Corp (INCY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Promising Pipeline Developments - GuruFocus
Oppenheimer raises Incyte stock price target on earnings beat By Investing.com - Investing.com South Africa
Oppenheimer raises Incyte stock price target on earnings beat - Investing.com UK
Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch
Incyte Welcomes Suky Upadhyay as EVP, CFO - Contract Pharma
Incyte (NASDAQ: INCY) posts 2025 growth, outlines pipeline and pay plan - Stock Titan
Morgan Stanley raises Incyte stock price target on solid results - Investing.com
Morgan Stanley raises Incyte stock price target on solid results By Investing.com - Investing.com Canada
Robust Q1 2026 growth at Incyte (NASDAQ: INCY) driven by key drug sales - Stock Titan
TD Cowen raises Incyte stock price target to $124 on demand outlook - Investing.com
Incyte (INCY) Reports Strong Q1 2026 Sales Growth and Strategic Developments - GuruFocus
Q4 2025 Incyte Corp Earnings Call Transcript - GuruFocus
Incyte (INCY) Q2 2025 Earnings Transcript - The Globe and Mail
Incyte Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Incyte (INCY) Exceeds Q1 2026 Earnings Expectations with Strong Drug Demand - GuruFocus
Incyte Appoints Suketu (Suky) Upadhyay as Chief Financial Officer - BioSpace
Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates - BioSpace
INCY Q1 Earnings and Revenues Beat Estimates on Higher Product Sales - Yahoo! Finance Canada
Incyte Q1 2026 slides: 21% revenue growth, portfolio diversification accelerates - Investing.com
Earnings call transcript: Incyte Q1 2026 beats earnings expectations - Investing.com
Incyte (INCY) Reports Strong Q1 Earnings with Significant Revenue Growth - GuruFocus
Incyte (INCY) Posts Strong Q1 Revenue and Plans for New Product Launches - GuruFocus
Incyte (NASDAQ:INCY) Beats Q1 Estimates and Unveils Robust Pipeline Catalysts - ChartMill
Incyte (INCY) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Q1 2026 Incyte Corp Earnings Call Transcript - GuruFocus
Is Incyte (INCY) 3.3% Undervalued After Q1 2026 Earnings Beat? E - GuruFocus
Incyte stock falls nearly 4% despite beating first quarter estimates By Investing.com - Investing.com South Africa
Incyte names Suketu Upadhyay as CFO effective May 4 - Investing.com
Incyte (NASDAQ:INCY) Exceeds Q1 CY2026 Expectations - Yahoo Finance
Incyte: Q1 Earnings Snapshot - kare11.com
Incyte (INCY) Q1 2026 earnings jump with 21% revenue growth and strong pipeline - Stock Titan
After Zimmer Biomet, Suky Upadhyay takes Incyte's finance helm - Stock Titan
Incyte (INCY) Set to Report Q1 Earnings with Strong Expectations - GuruFocus
Incyte earnings on deck: Povorcitinib prospects meet Q1 reality By Investing.com - Investing.com South Africa
Incyte earnings on deck: Povorcitinib prospects meet Q1 reality - Investing.com
Incyte Earnings: What To Look For From INCY - Yahoo Finance
INCY Technical Analysis | Trend, Signals & Chart Patterns | INCYTE CORP (NASDAQ:INCY) - ChartMill
Incyte gears up to report Q1 earnings: What can investors expect? - MSN
Incyte, BNY Mellon, Quantum-Si, Jabil, Levi Shock - TipRanks
Is It Too Late To Consider Incyte (INCY) After A 60% One-Year Surge? - Yahoo Finance
Munich Reinsurance Co Stock Corp in Munich Invests $6.07 Million in Incyte Corporation $INCY - MarketBeat
Incyte Corporation $INCY Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
FDA calls out Incyte’s Niktimvo efficacy claims on branded website - Medical Marketing and Media
Incyte Gears Up to Report Q1 Earnings: What Can Investors Expect? - The Globe and Mail
INCY Stock Price, Quote & Chart | INCYTE CORP (NASDAQ:INCY) - ChartMill
Incyte Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Incyte Q1 Preview: The Growth Story Remains Intact (NASDAQ:INCY) - Seeking Alpha
Ruffer LLP Has $2.51 Million Holdings in Incyte Corporation $INCY - MarketBeat
Australia clears first chemo-free option for relapsed follicular lymphoma - Stock Titan
Incyte (INCY) Stock Analysis | Incyte Corp Posts 8.5% EPS Miss Vs Consensus ViewsMost Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Incyte Corporation $INCY Stock Holdings Raised by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
0.10%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):